XML 48 R31.htm IDEA: XBRL DOCUMENT
v3.23.1

SHARE CAPITAL, WARRANTS AND OPTIONS (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Share Capital Warrants And Options |
SCHEDULE OF OF FAIR VALUE OF BROKER WARRANTS ASSUMPTIONS | The fair value of the broker warrants was calculated using the following assumptions: SCHEDULE OF OF FAIR VALUE OF BROKER WARRANTS ASSUMPTIONS
|  | March 31, 2023 |
Expected dividend yield |  |  | 0 | %
Stock price |  | $ | 1.73 |
Expected share price volatility |  |  | 77.52 | %
Risk free interest rate |  |  | 4.28 | %
Expected life of warrant |  |  | 2 year |
SCHEDULE OF WARRANT ACTIVITY | A summary of common share purchase warrant activity for the three months ended March 31, 2023 was as follows: SCHEDULE OF WARRANT ACTIVITY
|  | Number Outstanding |  |  | Weighted Average Exercise Price ($) |
December 31, 2022 |  |  | 1,098,786 |  |  |  | 1.96 |
Issued |  |  | 571,448 |  |  |  | 1.75 |
Exercised |  |  | - |  |  |  | - |
Cancelled / expired |  |  | (119,229 | ) |  |  | 2.04 |
Balance as at March 31, 2023 |  |  | 1,551,005 |  |  |  | 1.92 |
SCHEDULE OF NUMBER AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF OUTSTANDING WARRANTS | At March 31, 2023, the Company had outstanding common share purchase warrants exercisable to acquire common shares of the Company as follows: SCHEDULE OF NUMBER AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF OUTSTANDING WARRANTS
Warrants Outstanding |  |  | Expiry Date |  | Exercise Price ($) |  |  | Weighted Average remaining contractual life (years) |
| 683,905 |  |  | April 16, 20231 |  |  | 1.75 |  |  |  | 0.02 |
| 295,652 |  |  | August 3, 2024 |  |  | 2.40 |  |  |  | 0.26 |
| 221,448 |  |  | February 24, 2025 |  |  | 1.75 |  |  |  | 0.27 |
| 350,000 |  |  | March 22, 2024 |  |  | 1.75 |  |  |  | 0.22 |
| 1,551,005 |  |  |  |  |  |  |  |  |  | 0.77 |
1. | Subsequently, the expiry date of 643,299 warrants was extended to October 16, 2023 and the remaining 40,606 warrants expired on April 16, 2023.
SCHEDULE OF DEFERRED SHARE UNIT PLAN HAVE BEEN GRANTED | During the three months ended March 31, 2023, DSUs have been granted as follows: SCHEDULE OF DEFERRED SHARE UNIT PLAN HAVE BEEN GRANTED
|  | 2023 |
Number of DSUs outstanding at December 31, 2022 |  |  | 200,000 |
Number of DSUs granted during the period |  |  | 122,901 |
Number of DSUs outstanding at March 31, 2023 |  |  | 322,901 |

X
- Definition Disclosure of DSU's shares outstanding explanatory. + References No definition available. + Details
Name: | PNRL_DisclosureOfDSUsSharesOutstandingExplanatory
Namespace Prefix: | PNRL_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of number and weighted average remaining contractual life of outstanding warrants explanatory. + References No definition available. + Details
Name: | PNRL_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingWarrantsExplanatory
Namespace Prefix: | PNRL_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | PNRL_DisclosureOfShareCapitalReservesAndOtherEquityInterestAbstract
Namespace Prefix: | PNRL_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 47 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration